Latest / Investor Connect Podcast
Investor Connect 884: TEN Connect May 2026 - Part 4
In this episode of Investor Connect, we hear from Randy Hubbell, CEO of Soliris Endovascular, a medical device company developing peripheral endovascular technologies for PAD and dialysis access. Randy outlines the company's two advanced programs: Soliris SX, a self-expanding covered stent approved in 45 countries with over 15,000 sold and about $5M in recurring revenue, and a breakthrough-designated drug-eluting version that adds sirolimus to the stent edges to address edge restenosis. He shares Phase 2 interim results from a 115-patient study showing 95% patency compared to 70–75% for…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.